Valuation: Dynatronics Corporation

Capitalization 1.6K 1.38K 1.26K 1.2K 2.2K 155K 2.24K 15.09K 5.85K 73.11K 6.02K 5.89K 255K P/E ratio 2024
-0.26x
P/E ratio 2025 -0.06x
Enterprise value 6.31M 5.42M 4.96M 4.71M 8.67M 607M 8.82M 59.33M 23M 287M 23.67M 23.16M 1B EV / Sales 2024
0.23x
EV / Sales 2025 0.26x
Free-Float
46.81%
Yield 2024 *
-
Yield 2025 -
1 month-98.99%
3 months-97.50%
6 months-99.79%
Current year-99.75%
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0.05
1 year 0
Extreme 0.0001
0.17
3 years 0
Extreme 0.0001
0.91
5 years 0
Extreme 0.0001
8.95
10 years 0
Extreme 0.0001
18.75
Manager TitleAgeSince
Chief Operating Officer 46 31/05/2023
Chief Tech/Sci/R&D Officer 57 24/07/2022
Change 5d. change 1-year change 3-years change Capi.($)
-.--%-.--%-99.88%-99.99% 1.6K
+0.50%-2.64%+6.46%-15.83% 163B
+4.29%+4.65%-21.73%+40.80% 149B
+1.00%-1.75%-16.70%-27.75% 115B
+6.59%+5.24%-47.34%+5.10% 78.3B
+1.03%+6.36%+5.18%-6.10% 46.86B
+0.78%+0.27%-31.61%-36.54% 43.31B
+0.96%-4.45%-7.24%+24.07% 32.32B
+0.19%+0.44%-1.31%-13.31% 31.57B
+1.61%+3.03%-19.17%-8.66% 29.28B
Average +1.74%-3.19%-23.33%-13.82% 68.83B
Weighted average by Cap. +2.23%-4.43%-14.20%-1.51%

Financials

2024 2025
Net sales 32.53M 27.95M 25.58M 24.29M 44.72M 3.13B 45.49M 306M 119M 1.48B 122M 120M 5.17B 27.39M 23.54M 21.53M 20.45M 37.66M 2.64B 38.3M 258M 99.89M 1.25B 103M 101M 4.35B
Net income -2.7M -2.32M -2.12M -2.01M -3.71M -260M -3.77M -25.38M -9.84M -123M -10.12M -9.91M -429M -10.9M -9.37M -8.57M -8.14M -14.99M -1.05B -15.24M -103M -39.75M -497M -40.91M -40.05M -1.73B
Net Debt 6.2M 5.33M 4.88M 4.63M 8.53M 598M 8.67M 58.38M 22.62M 283M 23.28M 22.79M 986M 6.3M 5.42M 4.96M 4.71M 8.67M 607M 8.81M 59.32M 22.99M 287M 23.66M 23.16M 1B
Logo Dynatronics Corporation
Dynatronics Corporation is a medical device company. The Company designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. It markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The Company's products are marketed under brands including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. It offers a range of restorative products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Its offerings include orthopedic soft bracing and supports, patient care products, treatment tables, rehabilitation equipment, therapeutic modalities, and related supplies. Its orthopedic soft bracing products are designed for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury.
Employees
88

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DYNT.Q Stock